INTRODUCTION
The eagle-eyed amongst you will have noticed the 15 th year anniversary branding around our longstanding equine disease surveillance report logo -this will be a feature of all four 2019 quarterly reports to help us commemorate our 15 th uninterrupted year of full quarterly reports. The spring of 2005 not only saw Tony Blair's re-election for a third term as UK Prime Minister, Greece winning Eurovision and Liverpool FC's epic comeback in the Champions League final, but possibly more historically heralded the first full volume of the equine quarterly disease surveillance report produced through a new collaboration between the Department for Environment, Food and Rural Affairs (Defra), the Animal Health Trust (AHT) and the British Equine Veterinary Association (BEVA).
The addition of national disease surveillance reports for horses, ponies and donkeys to those already produced for farmed livestock and wildlife species was part of the UK Government's commitment to enhance veterinary surveillance that had been described in a strategy document published in 2003. In the spirit of partnership that was being promoted through the Animal Health and Welfare Strategy, the new equine disease reports aimed to bring industry and government together to collate anonymised quarterly information on numbers of diagnostic tests performed and discussion of positive results obtained for specified equine infections and disease syndromes arising from the broad network of diagnostic laboratories that serves the equine industry in the UK. The intention was also that these data would be accompanied by more in-depth discussions of unusual cases and outbreaks, current issues of concern for equine health and welfare and promotion of research findings of relevance.
That first edition report of volume one for January-March 2005 collated data from some 12 laboratories in addition to the AHT; by comparison 30 or more laboratories now consistently contribute to the reports. That first report included a review of the atypical form of equine herpesvirus-1 (EHV-1) abortion in which viral lesions are restricted to the placenta, a description of a confirmed case of contagious equine metritis organism (CEMO) infection in an imported Warmblood stallion in south west England and a report on investigations into reported adverse reactions to the live attenuated strangles vaccine Equilis StrepE, which had first been launched in the UK in autumn 2004.
Review of reported cases revealed a somewhat uncanny parallel with recent events in the UK with the following reference to "An imported Spanish stallion at stud [that] unexpectedly tested positive for EVA by VN [virus neutralisation blood test] during March [2005] . The animal had been in the UK for several years and was thought to have been blood tested, although no record of this was found. The Divisional Veterinary Manager was notified and appropriate control measures applied under the EVA Order 1995." On that occasion the stallion was subsequently virologically cleared and no notification of confirmed EVA in the UK was made to the OIE. Since that inaugural volume the quarterly surveillance reports have notified and reviewed a wide range of endemic, re-emerging and exotic disease threats, some of which have been subsequently realised here in the UK -the confirmations of EIA, CEM and EVA all in 2012 being prime examples and others have been seen in mainland Europe, including Dourine in Italy, Glanders in Germany and West Nile virus across a widening area in Europe.
Finally, the team behind the reports would like to extend their sincere thanks to all those who have contributed to their contents and production over the past 15 years -this includes members, past and present, of the project steering group representing the AHT disease surveillance group, BEVA and Defra/ APHA who have all helped draft, critically review and improve each report and guide the project during its various contracts; all the authors of the many focus articles who have freely given of their expertise and greatly enhanced the relevance and readability of the reports and finally we are most indebted to all the laboratories that through their continued contribution of data have made the UK's equine quarterly disease surveillance reports an unparalleled window on diseases affecting the British and global horse population. We hope you will continue to support the initiative and we remain grateful for this support.
Control: Pre-breeding serological screening as outlined in HBLB Code of Practice https://codes.hblb.org.uk/index.php/ page/53 Vaccination (with an inactivated vaccine in the UK) for stallions. Serological testing must demonstrate freedom from disease prior to initiating vaccination courses. Where an unvaccinated/lapsed vaccinated stallion is found to be positive, infectious status must be established by semen testing to rule out persistent shedding status. Confirmation of a positive case warrants movement restrictions, biosecurity and hygiene measures and laboratory clearance.
Notifiable in the UK: EVA Order 1995 -notifiable in all stallions and in mares that have been covered in the preceding two weeks of a seropositive test result. It is not notifiable if a non-bred mare or gelding are found to be seropositive. However, infectious status should still be established in non-bred mare and geldings by repeating serology two weeks later, if titres are stable, there is no evidence for current infection and the seropositivity demonstrates previous exposure.
Zoonotic Risk: None recognised.
Equine Viral Arteritis (EVA)
On 4 April 2019, the UK's Chief Veterinary Officer confirmed two cases of Equine Viral Arteritis (EVA) in non-Thoroughbred stallions on a premises in Dorset. A third case was confirmed in an additional stallion on the same premises on 15 April 2019. A fourth case was also confirmed in a non-thoroughbred stallion at a premises in Devon on 10 May 2019 and this case has epidemiological links to the outbreak in Dorset. Restrictions on breeding have been put in place on the animals, as in accordance with EVA Order 1995.
DEFRA, BEVA and AHT are advising vigilance and encouraging people to re-familiarise themselves, where necessary, with the possible presentations of the disease and routes of transmission.
 Whilst acute infection may present with clinical respiratory signs or abortion, signs may also be inapparent  The virus can be transmitted directly or indirectly via all bodily fluids  The disease has the potential for subclinical respiratory transmission as well as the more commonly recognised venereal route of spread. At this time of year, pre-breeding testing prior to AI or natural mating of all mares and stallions (including teasers) is vital and especially in breeds or on yards where it has not previously been common practice. It should also be remembered that importing breeding animals from countries endemic with EVA, including mainland Europe, carries a large risk of also importing EVA. Breeding mares and stallions should be tested for EVA within 28 days before travel and testing should be repeated at least 14 days after arrival and prior to commencing natural mating or AI.
Further information on the disease can be obtained from HBLB Codes of Practice https:// codes.hblb.org.uk/index.php/page/53 Also see page 19 of this report for a focus article on EVA, authored by James Crabtree, Equine Reproductive Services (UK) Limited. The article discussed the epidemiology of Equine Artertitis Virus and its prevention.
Respiratory Diseases
Equine Herpes Virus-1 (EHV-1) Neurological Disease On 9 April 2019, AHT confirmed a case of EHV-1 neurological disease on a premises in London. The affected horse was an unvaccinated teenaged non-Thoroughbred that presented with ataxia and a serous nasal discharge. The positive diagnosis was confirmed by PCR on a nasopharyngeal swab. There are around 30 unvaccinated in contacts and there has been a history of nasal discharge and coughing amongst the group during the last eight weeks. The neurological case was receiving medical treatment and was improving.
As per HBLB guidelines and with advice from AHT's epidemiology team, all horses on the premises underwent further diagnostic testing to establish the extent of the spread of infection among the group and to assist in establishment of preventative biosecurity measures to prevent further exposure and spread. Serological testing (complement fixation) demonstrated that the majority of animals on the premises had evidence of exposure, as was expected when history and clinical signs were evaluated alongside titres. However, a subset had low titres and no history of clinical signs. This group were treated as a separate entity, with strict biosecurity instigated. Voluntary movement restrictions were lifted once there had been no evidence of circulating virus among the group for two weeks, confirmed through establishing that there were stable serological titres between blood samples taken two weeks apart and close clinical monitoring, including temperature monitoring.
See Q4 2018 Defra report page 10 for further information on confirming a diagnosis of EHV-1 in a case demonstrating neurological signs.
Neurological Diseases

HBLB Surveillance Scheme
Animal Health Trust can test a nasopharyngeal swab and/or paired blood samples from suspected cases of equine influenza FREE OF CHARGE in our diagnostic laboratories, funded by the HBLB. Enter your details at www.aht.org.uk/equiflunet-form to sign up and AHT will send you sampling kits, including swabs and submission forms.
Tell-Tail Text Message Alert Scheme
In the case of an outbreak, notification will be reported by the text alert service (Tell-Tail) for UK equine practitioners sponsored by Boehringer Ingelheim. This free of charge service alerts practitioners to outbreaks of equine influenza, equine herpes abortion and equine herpes neurological disease in the UK via text message. Sign up to receive alerts at www.telltail.co.uk Equine Influenza (EI) EI outbreaks continue to be confirmed in the UK.
For further information on each specific outbreak see www.equiflunet.org Also see page 11 for UK Q1 summary and page 18 for a summary of Q1 European outbreaks OIE reported four outbreaks in Eswatini (Swaziland). Outbreaks involved; two cases with seven incontacts, one case with 35 in-contacts, one case (died) with two in-contacts and two cases with 56 in-contacts.
Atypical Myopathy
Since the beginning of 2019, RESPE has identified 13 cases of Atypical Myopathy by its sentinel veterinarians. Five of these cases were reported in early April.
Equine Infectious Anaemia (EIA)
Two separate cases were confirmed in Saskatchewan. Both involved subclinical animals.
Two cases were confirmed on separate premises in Texas, both were euthanased. One outbreak was confirmed in Iowa, with four positive Quarter Horses. Official quarantine was in place.
LABORATORY REPORT First quarter 2019
Virology
The results of virological testing for January to March 2019 are summarised in Table 1 
Bacteriology
A summary of the diagnostic bacteriology testing undertaken by different contributing laboratories is presented in Table 2 . The BEVA laboratory registering scheme is for the testing of CEMO, Klebsiella pneumoniae and Pseudomonas aeruginosa. Granting and maintenance of approval depends on a laboratory achieving correct results in quality assurance tests and reporting data to this report. BEVA publishes a list of approved laboratories annually. All 22 of the BEVA approved laboratories in the UK contributed data to this report. No equine bacterial notifiable diseases have been confirmed in the UK during the first quarter of 2019. 
APHA Salmonella results
Seventy-four samples were submitted in the first quarter of 2019 to the Animal and Plant Health Agency (APHA) and seventy-three of these were positive for Salmonella. This is the highest number of Salmonella isolations from equines in a quarter in the last five years. A large proportion of the reports have arisen from horses at rescue centres and largely relate to a limited number of premises with multiple submissions. From the incidents involving isolates typed by the APHA, the serovars/ phagetypes reported were: S. Typhimurium (17 samples), S. Bovismorbificans (15 samples), monophasic S. Typhimurium DT193 (12 samples), S. Newport (9 samples), S. Oslo (7 samples ), S. Enteritidis PT13a (6 samples), S. Mbandaka (3 samples), S. Kingston (2 samples) and single incidents of S. Agama and S. Coeln. Various different phagetypes of S. Typhimurium were isolated including DT8, DT40, DT41, DT104, U302, U323 and RDNC. Wild birds are likely to be associated with DT40, DT41 and RDNC whereas pigs are likely to be the origin of U302 and U323, monophasic S. Typhimiurium DT193 and S. Bovismorbificans. S. Typhimiurium DT8 is associated with farmed ducks and DT104 is likely to originate from humans or cattle/sheep. S. Enteritidis can be found in humans and poultry and both S. Newport and S. Agama are usually associated with badgers. For more information please see the 2017 Salmonella in livestock surveillance report www.gov.uk/government/ publications/salmonella-in-livestock-production-in-great-britain-2017
Toxicosis and Parasitology
A summary of diagnostic toxicosis and parasitology testing undertaken by contributing laboratories is presented in Tables 3 and 4 respectively. Results for toxicosis are based on histopathologically confirmed evidence of disease only (where applicable). No reported outbreaks in a region does not necessarily equate to the area being free from the disease. When a particular disease is reported as 'endemic', disease outbreaks are common and are at an expected level.
Equine Herpes Virus-1 (EHV-1) Abortion
Four separate outbreaks of EHV-1 abortion were confirmed by Rossdales Laboratories during the first quarter 2019.
One outbreak involved a single case of abortion in a unvaccinated Thoroughbred mare, among a group of four other pregnant mares. One outbreak involved a vaccinated Thoroughbred mare. One outbreak involved two vaccinated Thoroughbreds that both aborted on the same day. There were a further three pregnant mares in the group, of which one aborted nine days later. There were a total of 40 horses on the premises, including maiden mares and yearlings, with reports of non-specific respiratory signs within the preceding few months. The final outbreak involved two unvaccinated Warmblood mares that both aborted on the same day. There were a further 12 horses on the premises, including some youngstock that were reported to have had respiratory signs. For all, the positive diagnosis was confirmed by post mortem and PCR on fetal and placental tissues. 
EHV-1 Respiratory Infection
AHT confirmed two separate outbreaks. One was on a premises in Hertfordshire, with a total of eight non-Thoroughbreds displaying pyrexia. The second outbreak was a single unvaccinated non-Thoroughbred on a premises in South Wales that presented with coughing and pyrexia. For both, the positive diagnosis was confirmed by PCR on a nasopharyngeal swab.
EHV-4 Respiratory Infection
AHT confirmed six separate outbreaks. Five involved reports of single cases. One involved a group of unvaccinated yearling nonThoroughbreds. Clinical signs included coughing, inappetence, lethargy, lymphadenopathy, mucopurulent nasal discharge and pyrexia. For all, positive diagnoses were confirmed by PCR on a nasopharyngeal swab.
Neurological/Miscellaneous Diseases
No neurological or miscellaneous diseases were reported in the UK during the first quarter 2019.
Strangles
Strangles remains endemic in the UK. Please see the next page of this report for a Q1 summary from the Surveillance of Equine Strangles (SES) initiative, based at AHT. 
GRASS SICKNESS SURVEILLANCE report for the first quarter 2019
Equine Grass Sickness (EGS) surveillance scheme was established in spring 2008 to facilitate the investigation of changes in geographical distribution and incidence of the disease in Great Britain. Data gathered by this scheme is collated in a strictly confidential database. Having up to date reports from across the country will help provide an accurate representation of numbers of EGS cases nationwide and is vital to help continue epidemiological research into the disease. The data presented below must be interpreted with caution, as there is likely to be some bias in the way that samples are submitted for laboratory testing and subsequently reported. Consequently these data do not necessarily reflect true infectious disease frequency within the international equine population. A country with no reported outbreaks of a disease does not necessarily equate to the disease not being present in that country.
Information on infectious disease outbreaks is obtained through the International Collating Centre (ICC), based at the Animal Health Trust and generously supported by contributions from International Thoroughbred Breeders Federation members. This section provides a summary of international infectious disease outbreaks reported during Q1 2019.
National and international equine disease outbreaks are reported on a daily basis by the ICC. Interim ICC reports are e-mailed to subscribers, through a dedicated ICC circulation list, please contact equinesurveillance@aht.org.uk to receive these reports.
Interim and quarterly ICC reports can also be found at www.aht.org.uk/disease-surveillance/icc-reports
Each table below summarises the number of disease outbreaks reported by a country. Each reported outbreak may involve more than one case. 
Contagious Equine Metritis (CEM)
Outbreaks of CEM were confirmed in 10 Icelandic horses on four separate premises. Positive diagnoses were confirmed by culture and/or PCR on genital swabs.
Equine Herpes Virus-1 (EHV-1) Abortion
The positive diagnosis was confirmed by PCR on fetal tissues.
Two mares aborted in their ninth and tenth month of pregnancy respectively. One week prior, two horses suddenly developed neurological signs, consistent with EHV-1 neurological disease and were euthanased.
Three outbreaks involved one case, one involved two cases and one involved four cases. When reported, one outbreak involved a Thoroughbred mare.
Seven separate cases of abortion were confirmed. For one case, the affected mare was a nine-yearold Thoroughbred with unknown vaccination status. Positive diagnosis was confirmed by PCR on fetal lung puncture aspirate and swabs of uterine discharges and endometrium.
EHV-1 abortion was reported in eight Thoroughbreds on eight separate premises. Six of the animals were vaccinated.
Both outbreaks were reported to involve single cases of abortion.
Three outbreaks involved Thoroughbreds, two involved vaccinated horses.
Seven cases of abortion due to EHV-1 were reported on seven separate premises. 
INTERNATIONAL DISEASE OCCURRENCE
EHV-1/-4 Respiratory Infection
International: EHV remains endemic in most countries.
Strangles
International: Strangles remains endemic in most countries.
Eastern Equine Encephalitis (EEE)
So far in 2019, there have been confirmed cases of EEE in Florida (seven cases) and Georgia (one case).
Equine Encephalosis Virus (EEV)
Gauteng reported 60 cases of EEV, Mpumalanga reported 13 cases and Kwa-Zulu Natal, Limpopo, North-West and the Western Cape reported 13 cases between them.
EHV-1 Neurological Disease
One outbreak involved two unvaccinated horses, one involved seven horses with unknown vaccination status and one involved three vaccinated horses. Clinical signs included; ataxia, coughing, nasal discharge pyrexia and recumbency.
Two outbreaks involved a single case and one involved 16 cases, with two of these requiring euthanasia All three outbreaks had multiple horses affected. Both respiratory and neurological signs were reported. Two outbreaks had reports of two horses being euthanased and one had three euthanased due to severe neurological signs A total of 13 outbreaks of EHV-1 neurological disease were confirmed in eight states. Three outbreaks involved reports of multiple cases.
Rabies
A case of rabies was confirmed in a Quarter Horse in Gordon County, GA. Clinical signs included inappetence, pyrexia, mild colic and pawing. The animal was euthanased. 
Equine Influenza report for Q1: Summary of data for region resolution based outbreaks in Europe
Only outbreaks with details reported on the region of a country affected are included in this summary report. 
Introduction
The recent notifications by the UK Chief Veterinary Officer of equine viral arteritis (EVA) (see page 3 of this report) infection detection in non-Thoroughbred stallions in Dorset and Devon has heightened our awareness of EVA however, there still remains some confusion in the eyes of the general public regarding the importance of this disease and the ways in which it can be transmitted within the equine population. EVA is not just a reproductive disease of concern in breeding stallions. This article aims to highlight the current importance of EVA and its potential routes into and around the UK via the venereal and respiratory routes.
Equine viral arteritis (EVA) is a disease of horses, donkeys and other equids caused by equine arteritis virus (EAV). The vast majority of EAV infections are subclinical, although clinical outbreaks are most importantly associated with abortion, neonatal mortality and establishment of persistent infection in stallions (Doll et al. 1957; Timoney et al. 1986; Pronost et al. 2010; Balasuriya et al. 2016) . Clinical signs of EAV infection vary greatly depending on a variety of factors including the challenge dose, route of infection and virus strain (Balasuriya et al. 2016) .
Clinical signs
Acute infection can vary from entirely subclinical to lethal, with horses primarily demonstrating an influenza-like syndrome (Pronost et al. 2010; Balasuriya et al. 2016) . Some highlighted clinical signs include dependent oedema affecting the scrotum, mammary gland, ventral trunk, and limbs; rhinitis with nasal discharge; conjunctivitis with ocular discharge, periorbital and/or supraorbital oedema ('pink eye'); pyrexia and leukopenia (Doll et al. 1957; Timoney and McCollum 1993; Wood et al. 1995; Balasuriya et al. 2016) . The reproductive consequence of the condition is abortion occurring between 2 and >10 months of gestation and affecting 10-70% of infected mares without premonitory signs (Doll et al. 1957; Cole et al. 1986; Timoney and McCollum 1993; Balasuriya et al. 2016) . Infection of entire male horses may result in a persistent state of infection or carrier status with the virus persisting in the accessory sex glands; no carrier status exists in mares, geldings and pre-pubertal colts (Timoney and McCollum 1993) .
Disease transmission
Balasuriya and MacLachlan (2014) have thoroughly reviewed and illustrated the routes of transmission of EAV. The infectious period for EVA is generally considered to be between 2 days and 2 weeks post infection. Horses with acute infection spread EAV horizontally via respiratory tract secretions for 7 to 14 days (McCollum et al. 1971) however, close and direct contact appears to be necessary for transmission (Timoney, 1988) . Despite this, horses could potentially be infectious for longer, up to a theoretical maximum of 28 days (Holyoak et al. 2008) . EAV can also be transmitted by aerosol from urine and other body secretions of acutely infected horses, aborted fetuses and their membranes (Balasuriya and MacLachlan, 2014) . Lateral transmission of EAV also can occur through contaminated fomites such as personnel, clothing, vehicles, and equipment (Timoney, 1988; Timoney and McCollum, 1993) . Venereal transmission of EAV contained in the semen of stallions that are either acutely or chronically infected with EAV is the other important route of natural transmission of the virus (Timoney et al. 1986; Timoney et al. 1987) .
Mares that become infected following natural mating or artificial insemination with fresh, chilled, or frozen semen can subsequently transmit the virus by the respiratory route to susceptible cohorts in close proximity (Cole et al. 1986 ). An infectious mare presented to a susceptible stallion for natural mating can infect him via the respiratory or venereal route. EAV has also been reported to spread among non-breeding stallions by the masturbates of acutely or chronically infected stallions (Guthrie et al. 2003) .
Stallion carrier status
The carrier state exists in 30-60% of stallions that are infected (Timoney et al. 1986; Timoney et al. 1987; Neu et al. 1988 ). Infection of stallions will result in one of three potential outcomes: A short term convalescent carrier lasting a few weeks after clinical recovery; an intermediate carrier state may last for 3 to 7 months; a long term carrier may last for the entire life of the stallion (Timoney et al. 1987; Hurtington et al. 1990; Balasuriya and MacLachlan, 2014) . It has been suggested by Balasuriya and MacLachlan (2014) that some persistently infected, long-term carrier stallions cease to shed virus after years of persistent infection, with no apparent later reversion to a shedding state. However, the mechanism responsible for this spontaneous clearance of EAV is not clear (Balasuriya and MacLachlan, 2014) . Nevertheless, as the carrier state is testosterone dependent, it has been demonstrated that surgical castration results in elimination of the virus (Little et al. 1991) .
Prevalence EAV has an almost worldwide distribution (Timoney and McCollum 1993) and outbreaks of the disease have been reported from countries including Switzerland, Austria, Poland, Italy, the UK, Ireland, Spain, the Netherlands, Canada, the United States, and Argentina (Balasuriya et al. 2016 ). Iceland, Japan, and New Zealand have declared themselves free from the virus. EAV seroprevalence varies between countries and between horses of different breeds and ages within the same country (Balasuriya et al. 2016 ).
Of particular note are the great discrepancies throughout Europe regarding the control of EVA between countries and this has significant effects on international trade (Newton 2007) . This can be evidenced through the seroprevalence of antibodies to EAV which have been reported for the Netherlands and Germany at 14% and 20% respectively (DeBoer et al. 1979; Eichhorn et al. 1995 ) compared 1.3% in the UK (Newton et al. 1999 ). In addition a recent report confirmed EVA circulation in French breeding stock and estimated that there were 239 cases and 177 outbreaks, identified by seroconversion to EAV, between 2006 and 2013 (Amat et al. 2016 ).
European disease outbreaks
The disease's first known entry to the United Kingdom was in 1993 introduced by an AngloArabian stallion imported from Poland (Wood et al. 1995) . Between 1997 and 2018, there have been four notifications by DEFRA to the World organization for Animal Health (OIE) of the detection of EAV in the UK (Table 1 *'Date started' refers to the date of the serological blood tests that triggered suspicion of a problem with each of these stallions. **'Date reported' is the date reported to the OIE on the basis of a positive virus isolation test result for EAV in semen conducted by APHA Weybridge. ***'Date resolved' is the date that DEFRA considered the outbreak resolved -this was on the basis of re-export of the animal back to country of origin in 2005 and 6 weeks after the animals were gelded for the other three incidents.
In addition the British Equine Veterinary Association (BEVA) provides guidance on EVA (https://www.beva.org.uk/Home/Resources-ForVets/Guidance/BEVA -BEF-BHS-Equine-ViralArteritis-Briefing-Document) as well as the welle s t a b l i s h e d a n d r e s p e c t e d v o l u n t a r y recommendations made in the 2019 edition of the Horserace Betting Levy Board (HBLB) Codes of P r a c t i c e ( h t t p s : / / c o d e s . h b l b . o r g . u k / downloads/2019/EVA.pdf). Clinical cases suspected as being EVA must, by Law, be reported to DEFRA/ APHA. However, given that EVA can present in a very similar manner to other diseases, which in the UK would be far more likely, diagnosis of EAV infection is laboratory dependent and based on virus isolation (VI), detection of viral nucleic acid by polymerase chain reaction (PCR) or demonstration of an antibody response that is not explained by vaccination.
Prevention of EVA
Protection against EVA in susceptible horse populations is via exclusion of the disease, preventing the dissemination of EAV in breeding populations, minimising the risk of abortion outbreaks, deaths in young foals and establishment of the carrier state in colts and stallions (Timoney and McCollum 1993) . Targeted vaccination strategies protect stallions and sexually immature colts from infection. In the UK, the vaccine Equip Artervac 1 is licensed for use in stallions. It is essential to demonstrate that a stallion was serologically negative prior to vaccination and that the post-vaccination seropositive status is consistent with the history of vaccination. Inadequate certification, missed booster vaccinations and issues with vaccine supply all complicate the interpretation of disease free status and exposure risk (Crabtree and Newton, 2018) . Although there is very good uptake in Thoroughbred stallions, the uptake in Sport Horse stallions is lower. Factors contributing to this may include: the cost of vaccination, which requires six-monthly boosters; risk of vaccine reactions in actively competing stallions; added complications related to collection and cryopreservation of semen for international export and international travel outside of the EU for competition. Paradoxically, the latter reason may actually represent an infectious risk factor for exposing the stallion to EAV via the respiratory route.
Importation of horses
Importation of horses to the UK presents risks for the introduction of EVA and it is important to accept there are currently no statutory requirements for pre-or post-entry testing of horses entering the UK from EU member states.
Following the UK outbreak in 1993 (Wood et al 1995) researchers at the Animal Health Trust (AHT) recommended serologically screening horses whilst still in the country of origin, prior to importation (Newton et al 1999) and this still holds true in 2019. The HBLB Codes of Practice suggest serological screening of horses, in their country of origin, within 28 days of proposed importation. Horses can be isolated and repeat screening performed on arrival to the UK. Positive titres in stallions, increasing titres in geldings or mares, or discrepancies warrant continued isolation and further investigation.
Importation of semen
The persistence of virus in the accessory sex glands of the entire stallion and shedding of EAV in semen is responsible for its persistence in the horse population and allows its potential widespread dissemination across international boundaries via chilled and cryopreserved semen. Mechanisms are in place to prevent the introduction of EVA via semen imports through semen certification. Semen should be certified by an official veterinary surgeon in the country of origin to confirm that the stallion and therefore his semen is free from infections, including EAV. Chilled semen reaching the UK border without certification will likely pass border control agencies and be delivered to its destination into the hands of a veterinary surgeon or technician to inseminate a mare. The consequences of infecting a mare with semen containing EAV are significant. Frozen semen importation is more complicated as semen may have been frozen a long time ago; certification may be provided but it is difficult for the importer to determine its accuracy, there is also no requirement for this certification to accompany the semen if transferred or sold on within the UK. Illegally imported semen or semen inseminated by unqualified persons, clearly bypasses all regulation.
Summary
The UK is at biggest risk of introduction of EVA through importation of infected horses, especially stallions, be it temporary or permanent, or through the importation of infected semen. Introduction of an infected stallion could be prevented by preimport serological screening. If a carrier or a subclinically infected and infectious horse is introduced, there is the potential for disease to spread horizontally without a stallion mating a mare; if the stallion is utilised for breeding there is a significant risk of disease spread which may be associated with minimal or no clinical signs.
The HBLB Code of Practice for EVA and BEVA guidelines on pre-breeding disease screening should therefore be adopted to maintain our serosurveillance for EAV, despite the lack of legal requirement for this to be done. If EVA enters the UK through semen or subclinically infected and infectious horses, there is the potential for EAV to subsequently spread horizontally via the respiratory route to other mares, geldings and stallions and the potential for a wider disease outbreak. In dealing with this sort of situation we would urge attending veterinary surgeons to advise and work with their clients in adopting the disease control measures outlined on pages 26-28 of the 2019 HBLB Codes of Practice.
POST MORTEM EXAMINATIONS report for the first quarter 2019
Details about post-mortem examinations were reported by four UK Veterinary Schools and three other contributing laboratories. Data from each laboratory is organised by the laboratories regional location. There may be more than one laboratory reporting information for each region.
East and South East of England
A total of 94 cases were examined by post mortem 40 aborted fetuses and fetal membranes were examined. PCR and histopathology was performed to screen for Equine Herpes Virus-1/-4 infection in all cases. *Where abortion/still born cases had no final diagnosis reached, hypotheses were made for each case with the intention for interpretation by the submitting veterinarian, relating fetus and fetal membranes post mortem findings to concurrent clinical history to affirm the most likely conclusion. For every abortion/still birth case, congenital and common infectious causes had been ruled out.
19 cases of neonatal death (within first week of age) were examined. One case had marked icterus, likely secondary to neonatal isoerythrolysis. Eight were associated with dystocia. Four cases had sepsis. Six cases had congenital malformations; one case had marked torticollis, moderate wry nose and flattening of the trachea. One case had bilateral congenital micropthalmia, bilateral cheiloschisis and mild palatoschisis. Two cases had bilateral carpal contracture. One case had flexural deformity of both forelimbs. One case had suspected collagen dysplasia (cutaneous asthenia).
Two cardiovascular cases were examined. One case was found to have idiopathic dilated right cardiomyopathy. One case had a ruptured aorta, with a dissecting pseudoanaeurysm. One case had alteration of the normal foetal blood flow secondary to malpresentation
One case had failure of the cervical star to rupture with secondary tearing of the allantochorion through the body. Premature placental separation is often considered a predisposing/causing factor Trauma 2 One case had umbilical herniation/eventration of the intestine with subsequent intestinal rupture, funisitis and amnionitis. The evidence of meconium aspiration and adrenal cortico-nodular hyperplasia is likely associated with stress.
One case had hypovolemic shock secondary to haemoabdomen. The source of haemorrhage could not be determined. One neoplasia case was examined and diagnosed with T cell large B cell lymphoma, with lymph node masses and a moderately firm spleen.
Umbilical Cord Torsion
One neurological case was examined and diagnosed with marked bilateral cholesterol granulomas, present within the skull.
Three respiratory cases were examined. One case was a post-anaesthetic death with upper and lower airway oedema and myopathy. One case had a marked sinusitis with a concurrent hypoalbuminaemia and an abdominal effusion of uncertain aetiology. One case had fatal exercise-induced pulmonary haemorrhage, with multofocal, acute, severe petechial and lobular haemorrahge.
Seven welfare cases were examined. Five had a poor body condition, no fat stores, Gasterophilus intestinalis, mild to moderate tapeworm, mesenteric thombi with Strongylus vulgaris and mass emergence of cyathostomes. One case had poor body condition, no fat stores, Gasterophilus intestinalis, mild to moderate tapeworm, the trachea and lungs were infected with Dictyocaulus arnfieldi and there was evidence of mass emergence of cyathostomes. The final case had a poor body condition, no fat stores, Gasterophilus intestinalis, moderate tapeworm, mesenteric thombi with Strongylus vulgaris, mass emergence of cyathostomes worms and large amounts of sand in the right dorsal colon.
Scotland
A total of 13 cases were examined Seven gastrointestinal cases were examined. One case had a small intestinal strangulation caused by a lipoma. Two cases had colitis and typhlitis. One case had marked, regionally extensive, necrohaemorrhagic and ulcerative typhlocolitis. One had a faecal impaction of the left dorsal colon. One case had trichobezoar with impaction and obstruction of the right dorsal colon. The final case had impaction and displacement of the large colon following surgery for epiploic foramen entrapment.
One hepatic case was examined. Macroscopic findings were consistent with acute hepatocellular damage. A toxic insult was suspected but not definitively identified.
Two musculoskeletal cases were examined. One case had a left hind deep digital flexor tenosynovitis. One case had a left stifle degenerative joint disease secondary to osteochondritis dissecans (OCD).
One case of neoplasia was examined. There were morphologically similar masses in the ileum, adjacent mesentry, spleen and left ventral colon. The case had peritonitis and a ruptured left ventral colon.
One neurological case was examined. The case was a "sidewinder" with abnormal gait; gluteal muscle haemorrhage was observed but this was possibly secondary to trauma due to falling as a consequence of a neurological disorder.
One welfare case was examined, there were no specific findings but the case had a thin body condition.
South West England
A total of seven cases were examined One neonatal death was examined and diffused reddening of the cerebellum was identified. On histopathology, there were numerous, multifocal haemorrhages throughout the brain and cerebellum. In absence of an inflammatory reaction, interpreted as secondary to traumatic foaling.
Two cardiovascular cases were examined. In one, the cranial mesenteric artery was largely occluded by red pink friable material (thrombus) containing several white worms. The thrombus extended into the aorta and the right renal artery. A diagnosis of verminous arteritis was made from macroscopic findings and histopathology. In the second case, macroscopically, the aortic bifurcation contained a thrombus occluding or partially occluding the origins of the left internal and external iliac arteries and the right internal iliac artery. A diagnosis of aortic thromboembolism was made.
One genitourinary case was examined. On the cut surfaces of both kidneys, more marked in the left kidney, there were prominent well-defined areas within the medulla (papillary ducts) which had reddened borders encircling pale tan-green areas suggesting necrosis. A diagnosis of medullary necrosis was made, with a presumptive ischaemic cause.
Three gastrointestinal cases were examined. One case had pitted ulcers covering a 6.5x1.5cm area of the mucosa, within the non-glandular stomach, adjacent to the margo plicatus. One was found to have several raised, dark red, nodular masses in the wall of the right ventral colon, with extensive subacute haemorrhagic enteritis and lymphadenopathy. On histopathology, scattered vessels within the mucosa and submucosa appeared thrombosed and the submucosa was oedematous, haemorrhagic and inflamed with distended congested vessels. A diagnosis of extensive, subacute haemorrhagic enteritis with haemorrhagic lymphadenopathy was made. One gastric impaction and rupture was examined, with splenic rotation also present.
Northern Ireland
A total of three cases were examined One aborted fetus and fetal membranes were examined. No final diagnosis was reach but infectious causes were ruled out.
Two gastrointestinal cases were examined. Both were found to have cyathostomiasis. The small intestine was flaccid with copious watery contents. The caecum was filled with fluid contents and the caecal mucosa was thickened dark brown with necrotic material coating the surface. The mucosa of the proximal half of the colon was similarly thickened and coated by necrotic material and numerous red worms 1-2cm long within the superficial mucosal coating. The lymph nodes along the border of the caecum and affected colon were markedly enlarged, firm and nodular with multiple pale areas within the tissue.
